Clinical trial
REACT-01: Reversing Autoimmunity Through Cell Therapy
NCT06465147 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REACT-01: Reversing Autoimmunity Through Cell Therapy
- Lead sponsor
- Seattle Children's Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 16, 2024
- Completion date
- October 31, 2041
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus